Syneos Health Inc (SYNH) Return on Investment ROI from the second quarter of 2023 to second quarter of 2022 and for the year 2023, average high and low, overall ranking from Jun 30 2023 to Jun 30 2022 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Syneos Health Inc   (NASDAQ: SYNH)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Syneos Health Inc's ROI from its second quarter of 2023 to the second quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Syneos Health Inc's ROI in the second quarter of 2023?
Syneos Health Inc achieved a return on average invested assets (ROI) of 1.1 % in its second quarter of 2023, which is below Syneos Health Inc's average return on investment, which stands at 5.93%.

ROI fell compared to the first quarter of 2023, despite the net income growth of % from the first quarter of 2023.

Within the Healthcare sector 201 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2023 from 1899 to 2315.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter
Y / Y Investment Change TTM -1.51 % -0.95 % 0.32 % 1.11 % 3.96 %
Y / Y Net Income Change TTM -74.39 % -38.84 % 35.89 % 138.81 % 563.7 %
Investment (TTM) in Millions 6,448 6,411 6,475 6,474 6,509
Return On Investment (TTM) 1.1 % 2.29 % 4.09 % 4.39 % 4.25 %
SYNH's Overall Ranking # 2315 # 1899 # 765 # 860 # 1127
Seq. Investment Change TTM -0.24 % -0.66 % -0.41 % -0.21 % 0.33 %
Seq. Net Income Change TTM -51.93 % -44.4 % -7.12 % 3.17 % 14.79 %
Net Income (TTM) in Millions 71 148 266 287 278

SYNH Company Profile >> Back to SYNH Roi Comparisons >> See Annual SYNH Return On Investment



Return On Investment SYNH's Ranking
Within: No.
Industry # 14
Sector # 202
Overall # 2315

Return On Investment Statistics
High Average Low
36.32 %
5.93 %
-8 %
(Dec 31 2016)   (Sep 30 2017)







Financial Statements
Syneos Health Inc's II. Quarter Investments $ 6,448 Millions SYNH's Balance sheet
Syneos Health Inc's II. Quarter Income $ 1 Millions Quarterly SYNH's Income Statement
SYNH's Income by Division See SYNH's Income by Division


SYNH Annual Return On Investment (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018
Total Investments in Millions 6,475 6,583 6,486 5,937 5,727
Y / Y Investment Growth -1.65 % 1.5 % 9.24 % 3.68 % -5.94 %
Net Income in Millions 266 235 193 131 24
Y / Y Net Income Growth 13.48 % 21.81 % 46.88 % 440.51 % -
Annual Return On Investment 4.12 % 3.57 % 2.97 % 2.21 % 0.42 %


Annual Roi Comment
In the fiscal year 2022 ROI improved to 4.12 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Laboratories Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
SYNH's Roi Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for SYNH's Competitors
Subscribers only: Roi for Syneos Health Inc's Suppliers
Subscribers only: Return On Investment for SYNH's Customers

Other Ratios
SYNH's Roa SYNH's Inventory Turnover Ratio SYNH's Growth Rates SYNH's Dividend Statistics
SYNH's Profitability Ratios SYNH's Asset Turnover Ratio SYNH's Dividend Growth
SYNH's Roe SYNH's Valuation Ratios SYNH's Financial Strength Ratios SYNH's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2023, within Healthcare Sector ROI
Skinhealth Systems Inc   2.85 %
Organogenesis Holdings Inc   2.75 %
Vanda Pharmaceuticals Inc   2.74 %
Bioplus Acquisition Corp   2.72 %
Zimmer Biomet Holdings Inc   2.67 %
Inmed Pharmaceuticals Inc  2.66 %
The Cooper Companies Inc   2.60 %
Integer Holdings Corporation  2.57 %
National Healthcare Corp  2.53 %
Royalty Pharma Plc  2.36 %
Medinotec Inc   2.35 %
Nuvasive Inc  2.17 %
Futuretech Ii Acquisition Corp   2.13 %
Atlantic Coastal Acquisition Corp Ii  2.08 %
Penumbra Inc  2.04 %
10x Capital Venture Acquisition Corp Iii  2.01 %
Blueriver Acquisition Corp  1.91 %
Biomarin Pharmaceutical Inc  1.71 %
Dih Holding Us Inc   1.59 %
Surgery Partners Inc   1.53 %
Viskase Holdings inc   1.51 %
National Vision Holdings Inc   1.34 %
American Shared Hospital Services  1.28 %
Steris Plc  1.13 %
Syneos Health Inc   1.09 %
Adapthealth Corp   0.99 %
Sbc Medical Group Holdings Incorporated  0.86 %
Infusystem Holdings Inc  0.76 %
Perrigo Company Plc  0.73 %
Cdt Equity Inc   0.69 %

Date modified: 2026-09-08T15:11:01+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.